文献速递糖尿病

预测性低血糖暂停系统在1型糖尿病家庭随机交叉研究中减少低血糖

Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
PubMed 文献 · Diabetes Care · 2018-08-08

PROLOG试验是一项为期6周的随机交叉研究,纳入103例6-72岁1型糖尿病患者,比较t:slim X2泵联合Basal-IQ预测性低血糖暂停算法(PLGS)与传感器增强泵(SAP)的疗效。主要结局CGM测量的血糖<70 mg/dL时间中位数在PLGS组为2.6%,SAP组为3.2%(差异-0.8%,95%CI -1.1至-0.5,P<0.001)。PLGS系统显著减少低血糖且无反弹高血糖。

要点

  • PLGS组血糖<70 mg/dL时间中位数2.6%,SAP组3.2%,差异-0.8%(95%CI -1.1至-0.5,P<0.001)。
  • PLGS组平均血糖159 mg/dL与SAP组159 mg/dL无显著差异(P=0.40)。
  • PLGS组血糖>180 mg/dL时间百分比32%与SAP组33%无显著差异(P=0.12)。

核心结论

  • Basal-IQ PLGS系统显著减少1型糖尿病成人和青少年低血糖,且无反弹高血糖。

研究设计与样本

  • 6周随机交叉试验,纳入103例6-72岁1型糖尿病患者,平均HbA1c 7.3%(56 mmol/mol)。
  • 比较t:slim X2泵联合Basal-IQ PLGS算法与传感器增强泵(SAP)治疗。

主要发现

  • CGM测量的血糖<70 mg/dL时间中位数从基线3.6%降至PLGS组3周期间的2.6%,SAP组为3.2%(差异-0.8%,95%CI -1.1至-0.5,P<0.001)。
  • 对应均值分别为4.4%、3.1%和4.5%,PLGS组血糖<70 mg/dL时间减少31%。
  • 平均血糖无升高(159 vs. 159 mg/dL,P=0.40),血糖>180 mg/dL时间百分比无增加(32% vs. 33%,P=0.12)。
  • SAP组发生1例严重低血糖事件,PLGS组无严重低血糖事件。
  • 平均泵暂停时间为104 min/day。

临床怎么用

  • PLGS系统可减少1型糖尿病成人和青少年低血糖时间,且不增加平均血糖或高血糖时间。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study evaluated a new insulin delivery system designed to reduce insulin delivery when trends in continuous glucose monitoring (CGM) glucose concentrations predict future hypoglycemia. RESEARCH DESIGN AND METHODS: Individuals with type 1 diabetes (n = 103, age 6-72 years, mean HbA1c 7.3% [56 mmol/mol]) participated in a 6-week randomized crossover trial to evaluate the efficacy and safety of a Tandem Diabetes Care t:slim X2 pump with Basal-IQ integrated with a Dexcom G5 sensor and a predictive low-glucose suspend algorithm (PLGS) compared with sensor-augmented pump (SAP) therapy. The primary outcome was CGM-measured time <70 mg/dL. RESULTS: Both study periods were completed by 99% of participants; median CGM usage exceeded 90% in both arms. Median time <70 mg/dL was reduced from 3.6% at baseline to 2.6% during the 3-week period in the PLGS arm compared with 3.2% in the SAP arm (difference [PLGS - SAP] = -0.8%, 95% CI -1.1 to -0.5, P < 0.001). The corresponding mean values were 4.4%, 3.1%, and 4.5%, respectively, represent-ing a 31% reduction in the time <70 mg/dL with PLGS. There was no increase in mean glucose concentration (159 vs. 159 mg/dL, P = 0.40) or percentage of time spent >180 mg/dL (32% vs. 33%, P = 0.12). One severe hypoglycemic event occurred in the SAP arm and none in the PLGS arm. Mean pump suspension time was 104 min/day. CONCLUSIONS: The Tandem Diabetes Care Basal-IQ PLGS system significantly reduced hypoglycemia without rebound hyperglycemia, indicating that the system can benefit adults and youth with type 1 diabetes in improving glycemic control.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Forlenza GP, Li Z, Buckingham BA, et al. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Diabetes Care. 2018. PMID: 30089663. doi:10.2337/dc18-0771

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。